10,650 Shares in BWX Technologies, Inc. $BWXT Acquired by Catalyst Capital Advisors LLC

Catalyst Capital Advisors LLC acquired a new position in shares of BWX Technologies, Inc. (NYSE:BWXT) in the 4th quarter, Holdings Channel.com reports. The fund acquired 10,650 shares of the technology company’s stock, valued at approximately $1,841,000.

Other institutional investors have also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of BWX Technologies during the 4th quarter worth approximately $9,754,000. Principal Financial Group Inc. raised its position in shares of BWX Technologies by 51.1% during the 3rd quarter. Principal Financial Group Inc. now owns 313,192 shares of the technology company’s stock worth $57,743,000 after purchasing an additional 105,879 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of BWX Technologies by 18.7% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 1,375,740 shares of the technology company’s stock worth $237,783,000 after purchasing an additional 216,707 shares during the last quarter. Thrivent Financial for Lutherans raised its position in shares of BWX Technologies by 7.3% during the 3rd quarter. Thrivent Financial for Lutherans now owns 669,636 shares of the technology company’s stock worth $123,460,000 after purchasing an additional 45,667 shares during the last quarter. Finally, Granahan Investment Management LLC acquired a new position in shares of BWX Technologies during the 3rd quarter worth approximately $1,941,000. 94.39% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Rex D. Geveden sold 10,000 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $204.81, for a total transaction of $2,048,100.00. Following the completion of the sale, the chief executive officer directly owned 202,491 shares of the company’s stock, valued at $41,472,181.71. The trade was a 4.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Kevin James Gorman sold 1,344 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $214.71, for a total transaction of $288,570.24. Following the sale, the chief accounting officer directly owned 114 shares of the company’s stock, valued at $24,476.94. This represents a 92.18% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 13,761 shares of company stock valued at $2,842,427 in the last ninety days. Company insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Zacks Research downgraded BWX Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Wall Street Zen upgraded BWX Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Bank of America lifted their price objective on BWX Technologies from $230.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday, March 25th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of BWX Technologies in a research note on Friday, May 22nd. Finally, TD Cowen began coverage on shares of BWX Technologies in a research note on Thursday, March 12th. They issued a “buy” rating and a $230.00 target price for the company. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, BWX Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $228.00.

BWX Technologies Stock Down 1.8%

Shares of NYSE BWXT opened at $195.65 on Friday. BWX Technologies, Inc. has a 52-week low of $123.12 and a 52-week high of $241.82. The firm has a fifty day moving average of $212.98 and a 200-day moving average of $199.60. The stock has a market capitalization of $17.92 billion, a PE ratio of 52.31, a P/E/G ratio of 3.28 and a beta of 0.78. The company has a quick ratio of 2.33, a current ratio of 2.40 and a debt-to-equity ratio of 1.58.

BWX Technologies (NYSE:BWXT) last announced its quarterly earnings data on Monday, May 4th. The technology company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.92 by $0.20. BWX Technologies had a net margin of 10.20% and a return on equity of 31.33%. The company had revenue of $860.22 million during the quarter, compared to analysts’ expectations of $837.47 million. During the same period in the previous year, the company earned $0.91 EPS. The business’s quarterly revenue was up 26.1% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. On average, analysts anticipate that BWX Technologies, Inc. will post 4.71 EPS for the current year.

BWX Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 5th. Stockholders of record on Tuesday, May 19th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Tuesday, May 19th. This represents a $1.08 annualized dividend and a dividend yield of 0.6%. BWX Technologies’s payout ratio is currently 28.88%.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.